The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of tyrosine kinase inhibitors and low dose immunotherapy in metastatic renal cell carcinoma.
 
Himanshu Gujarathi
No Relationships to Disclose
 
Minit Shah
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Nandini Menon
No Relationships to Disclose
 
Vijay Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Amit Joshi
No Relationships to Disclose
 
Santosh Menon
No Relationships to Disclose
 
Nilesh Sable
No Relationships to Disclose
 
Gagan Prakash
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); Aurigene Oncology Limited (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); Johnson and Johnson (Inst); NATCO Pharma (Inst); Roche (Inst)